The importance of screening has also recently been highlighted by a study of children and adolescent MEN1 patients, which indicated that 70% of patients developed a tumour before 18 years of age, including metastatic pancreatic NETs (Shariq et al. 2021). Here, MEN1 is linked to neoplasm.